US Democrats fear higher drug prices, trying to change text of trade deal
These practises open the door to Big Pharma companies and disastrous private health companies.
The struggle for farmers’ rights over their seeds and planting materials is not playing out only in India – it’s a global phenomena.
On intellectual property rights, there’s a serious gap between domestic Indonesian law and the structures of the proposed RCEP
As a second step, negotiators will focus on rules pertaining to intellectual property rights, competition policy and investment, which they aim to finalise by June 2020.
In its latest report on foreign trade barriers, the USTR, prompted by the pharmaceutical industry, takes aim at the pharmaceutical pricing and reimbursement policies in the European Union.
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
The new version of NAFTA forbids the US Congress from curtailing Big Pharma’s patent monopolies on some of the world’s most expensive drugs.
Free trade agreements like the RCEP will infringe on India’s intellectual property laws. India must stand its ground in the interest of public health.
Several Democrats said a closed-door meeting between United States Trade Representative failed to ease their concerns about the new US-Mexico-Canada Agreement’s provisions on labor, biologic drugs and some other issues.
Farmer and CSOs stressing that India should not agree to obligations with respect to IP on seed and planting materials at the RCEP negotiations as it hurt the livelihood of poor farmers.
The undersigned signatories are writing to strongly stress that the Regional Comprehensive Economic Partnership negotiations must not place any obligation on the Philippines or any other developing country to join or implement UPOV systems
RCEP negotiations must not include obligation to join or implement UPOV systems and in anyway undermine farmers’ rights
A mega free trade agreement, like RCEP that undermines farmers’ seed freedoms in a mega diverse country, with seed diversity and farmers’ knowledge is unacceptable, say over 50 groups and citizens
Democrats in Congress contend that the new pact would force Americans to pay more for prescription drugs, and their argument has dimmed the outlook for one of Trump’s signature causes.
Some Democrats in the US, like Canada’s generic drug industry, warn that the new biologics rule would keep drug prices high by requiring citizens to wait longer before they can get their hands on lower-cost similar drugs known as biosimilars.
In a letter to Congress, the groups demand that the pact’s giveaways to Big Pharma that would keep medicines unaffordable be removed before the pact is sent to Congress.
NAFTA 2.0 would effectively tie the US Congress’ hands in the struggle against rising drug prices.
The USMCA most closely reflects US IP laws, subjecting the US to almost no revisions of its current domestic intellectual property laws.
Can an intellectual property right or a license authorizing its use be deemed an ‘investment’ under bilateral investment treaties?